Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias (Q40991178)

25 September 2017

1 reference

title

Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias (English)

1 reference

25 September 2017

1 reference

Saksena S

1

1 reference

PubMed ID

8638025

25 September 2017

Madan N

series ordinal

2

1 reference

PubMed ID

8638025

25 September 2017

Lewis C

series ordinal

3

1 reference

25 September 2017

1 May 1996

1 reference

Progress in Cardiovascular Diseases

25 September 2017

1 reference

25 September 2017

38

1 reference

25 September 2017

6

1 reference

25 September 2017

445-454

1 reference

Recurrent Ventricular Fibrillation and Modes of Death in Survivors of Out-of-Hospital Ventricular Fibrillation

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Enhanced survival in patients with heart failure and life-threatening ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Long-term efficacy of subendocardial resection in refractory ventricular tachycardia: relationship to site of arrhythmia origin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Prevention of sudden arrhythmic death with implanted automatic defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Do patients with an implantable defibrillator live longer?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Influence of left ventricular function on outcome of patients treated with implantable defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

New medical technologies in a cost containment environment: Implantable antitachyarrhythmia devices

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Implantable defibrillation: eight years clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Survival in Patients with Depressed Left Ventricular Function Treated by Implantable Cardioverter Defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Survival of implantable cardioverter-defibrillator recipients. Can the iceberg remain submerged?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

The role of implantable cardioverter defibrillators in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Survival after implantation of the cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Management of recurrent ventricular tachycardia: economic impact of therapeutic alternatives

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

An analysis of the cost effectiveness of the implantable defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Automatic implantable cardioverter-defibrillator: is early implantation cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Transvenous Cardioverter Defibrillators: Cost Implications of a Less Invasive Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. MADIT Executive Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

The economic impact of transvenous defibrillation lead systems

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980008-9

7 January 2021

10.1016/S0033-0620(96)80008-9

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8638025